Alzheimer's disease is the commonest cause of presenile and senile dementia. Its incidence increases with advancing age, such that by the ninth decade as many as 36% of people may be affected. Although the characteristic neuropathological changes are fairly uniform from case to case, the condition is aetiologically heterogeneous.
Most recent molecular genetic studies have focused upon early onset "familial Alzheimer's disease" (FAD) because its pattern of inheritance suggests simple autosomal dominant transmission. In some families FAD is associated with mutations within exons 16 and 17 of the amyloid precursor protein (APP) gene on chromosome 21 '- and most of the remainder have been linked to a locus on the long arm of chromosome 14.5 The so-called "Volga-German" FAD kindreds are not linked to either APP or chromosome 14,5 thereby implicating the existence of at least a third locus. Thus, even apparently genetically simple FAD is genetically heterogeneous.
The genetics of common, late onset, and sporadic AD is more complicated, and this disorder is almost certainly both aetiologically and genetically heterogeneous. Complex segregation analysis suggests the possibility of one or two genes of major effect acting on a polygenic-multifactorial background.9 Putative susceptibility loci have been identified using non-parametric linkage methods on chromosomes 19 and 21.1011 Evidence for a susceptibility locus on chromosome 19 
Methods
The patient group consisted of 95 subjects with AD (44 males and 51 females): 34 were obtained from the Cardiff Memory Clinic; 28 were the first sampled members of families with more than one case of late onset AD; and 33 were recruited from local psychogeriatric hospitals. The mean age of the patient group was 73-5 years (SD 101) with a mean age of onset of 67-5 years (SD 9-3). The majority of patients had an age of onset greater than 65 years (n = 56). Patients met the NINCDS criteria for probable AD.'" An age matched control group consisting of 86 subjects was obtained from the community with the help of a local general medical practice who identified elderly non-demented persons from their practice records. Potential controls were screened with the Minimental State examination'6 and included if they scored 28 or higher. The mean age of the control group was 73-2 years (SD 6 07). All patients and controls were white.
With the approval of the local ethics committee and the consent of the patient's nearest relative, a sample of venous blood, anticoagulated with EDTA, was taken and DNA extracted from the white cells by a standard procedure. Digestion of the DNA and Southern blotting were also carried out by standard procedures. The Apo CII cDNA probe used was a 440 bp cDNA insert,'7 which detects allelic fragments of 3-8 kb and 3-5 kb, designated Al and A2 respectively, after digestion with TaqI. PCR analysis of apolipoprotein E genotypes was carried out by the method of Wenham et al. '8 Differences in allele and genotype frequencies were analysed by the method of Woolf.'9 The observed and expected genotype frequencies were compared in order to ensure that the loci were in Hardy-Weinberg equilibrium (HWE) using a X2 goodness of fit test. For the Apo E polymorphism, alleles 2 and 3 were collapsed because of small cell sizes. Haplotype frequencies were estimated according to a maximum likelihood procedure.20 The significance of linkage disequilibrium (D) was tested by a likelihood ratio test.
Results

APO CII ASSOCIATION STUDY
Results were obtained for 78 controls (38 males) and 89 patients (43 males) and are shown in table 1. The frequency of the smaller 3-5 kb allele in the control group was 0-52 and in the patient group 0 53. Forty seven of the patient group were known to have affected first degree relatives and, considering this subgroup, the frequency of the A2 allele was 0 57. This difference was not statistically significant (x2 = 1-31, df= 1, p = 025). The observed distributions of genotypes were close to the values expected on the basis of Hardy-Weinberg equilibrium in both the patients (X2 -0-2, df= 1, p=0 65) and controls (X2=3 16 , df= 1, p = 0O08).
APO E ASSOCIATION STUDY
Apo E genotyping was successful in 77 controls (38 males) and 86 patients (43 males) and Whatever the role apolipoprotein E plays in the pathogenesis of AD, it seems that there is an increased prevalence of the e4 allele in patients with AD. The prevalence may be increased further in family history positive cases. We estimate that considering the patient group as a whole, possession of the e4 allele increases the risk of AD by some 3-5-fold, and the relative risk in e4 homozygotes may be as high as 10.
This work was generously supported by a grant from the Mental Health Foundation. Additional funds were provided by the Swansea and Lliw Valley branch of the Alzheimer's Disease Society. We also thank Dr M E Robinson and Mrs Barbara Daniels of the Health Centre, Dinas Powys for their help in the collection of the control group; Professor G Wilcock, Department for the Care of the Elderly, Frenchay Hospital, Bristol, for clinical material; and Dr Allen Roses for access to data before publication.
1 Goate A, Chartier-Harlin MC, Mullan M, et al. Segrega- 
